ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

Survey Show Better Understanding Of Breast Cancer

December 12, 1980

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991